Literature DB >> 9918874

Trans-activator Tax of human T-cell leukemia virus type 1 enhances mutation frequency of the cellular genome.

H Miyake1, T Suzuki, H Hirai, M Yoshida.   

Abstract

Tax protein of human T-cell leukemia virus type 1 (HTLV-1) is a potent trans-activator of specific sets of target genes, and on the other hand, it is a trans-repressor of other sets of genes. It is also an inhibitor of the tumor suppressor protein p16(INK4a) and thus has been thought to contribute to induction of adult T-cell leukemia (ATL). We examined the mutagenic effects of Tax on a cellular gene, hypoxanthine guanine phosphoribosyltransferase (hprt), and LacI gene in lambda shuttle vector exogenously integrated in Big Blue Rat-2 (BBRat-2) cells. Expression of Tax in BBRat-2 cells enhanced the frequency of HPRT(-) phenotype severalfold. Tax-expressing cell clones, BBTax-1 and -2 established from BBRat-2 cells, gave rise to an average mutation frequency of 5.9 x 10(-5) in LacI gene, but Tax-negative cell clones, BBRat-C1 and -C2, showed 2. 1 x 10(-5). The 2.8-fold increase in mutation frequency in the presence of Tax indicates that Tax expression enhanced mutation frequency in chromosomal DNA. However, neither the mutation spectrum of base transitions, transversions, and deletions/insertions nor the loci of the mutations were significantly affected by Tax expression. These findings indicate that Tax has the capability to induce random mutations and suggest that Tax would be able to modulate cellular phenotypes through mutation of the cellular genome. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918874     DOI: 10.1006/viro.1998.9500

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Tax & rex: overlapping genes of the Deltaretrovirus group.

Authors:  Kathleen Margaret McGirr; Gertrude Case Buehuring
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

2.  The HTLV-1 Tax oncoprotein represses Ku80 gene expression.

Authors:  Razvan I Ducu; Tajhal Dayaram; Susan J Marriott
Journal:  Virology       Date:  2011-05-14       Impact factor: 3.616

3.  Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model.

Authors:  T Portis; W J Grossman; J C Harding; J L Hess; L Ratner
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Genotoxic stress and cellular stress alter the subcellular distribution of human T-cell leukemia virus type 1 tax through a CRM1-dependent mechanism.

Authors:  Michael L Gatza; Susan J Marriott
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.

Authors:  S Okazaki; R Moriuchi; N Yosizuka; K Sugahara; T Maeda; I Jinnai; M Tomonaga; S Kamihira; S Katamine
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

6.  Genetic evidence of a role for ATM in functional interaction between human T-cell leukemia virus type 1 Tax and p53.

Authors:  P L Van; K W Yim; D Y Jin; G Dapolito; A Kurimasa; K T Jeang
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 7.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

8.  The viral oncoprotein tax sequesters DNA damage response factors by tethering MDC1 to chromatin.

Authors:  S Mehdi Belgnaoui; Kimberly A Fryrear; Julius O Nyalwidhe; Xin Guo; O John Semmes
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

9.  Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response.

Authors:  Chandtip Chandhasin; Razvan I Ducu; Elijahu Berkovich; Michael B Kastan; Susan J Marriott
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

10.  HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular Transformation: "A Random Mutagenesis Model".

Authors:  Christophe Nicot
Journal:  J Cancer Sci       Date:  2015-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.